Lv31
228 积分 2024-08-09 加入
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial
4天前
已关闭
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
7天前
已完结
Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
12天前
已完结
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
17天前
已关闭
† Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia
19天前
已关闭
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
22天前
已关闭
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
22天前
已完结
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
22天前
已完结
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
22天前
已完结
Lipid-lowering efficacy of obicetrapib: A comprehensive systematic review and meta-analysis
22天前
已完结
皖公网安备34019202002308
